<DOC>
	<DOCNO>NCT01069822</DOCNO>
	<brief_summary>The main purpose study evaluate effect repeat dos AZD6765 ( drug develop treatment patient severe major depressive disorder ) PK ( pharmacokinetic ) profile Midazolam . ( The PK profile drug leave body act body . )</brief_summary>
	<brief_title>A Study Healthy Volunteers Assess Effect AZD6765 Midazolam Blood Levels</brief_title>
	<detailed_description />
	<mesh_term>Midazolam</mesh_term>
	<criteria>BMI 1930 Significant result CSSRS screening baseline Single arm preference IV procedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Midazolam</keyword>
	<keyword>Pharmacokinetics</keyword>
</DOC>